-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, April 2 News On April 1, the Medical Administration and Hospital Administration of the National Health Commission issued the "Management Standards for Long-term Prescriptions (Trial Draft for Solicitation of Comments)" (hereinafter referred to as the "Draft for Comments").
According to the needs of the patient's diagnosis and treatment, the long-term prescription is generally within 4 weeks.
In areas with conditions, it can be extended appropriately according to the characteristics of chronic diseases, and the longest is no more than 12 weeks.
According to actual conditions, various regions need to formulate long-term prescription applicable diseases and long-term prescription drugs.
It is worth noting that long-term prescriptions are encouraged by primary medical and health institutions.
When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs, national centralized procurement drugs, and national medical insurance catalog drugs.
After the doctor has issued a long-term prescription, the patient can choose to dispense and take medicine at medical institutions or social retail pharmacies.
The deadline for feedback on the "Draft of Opinions" is May 1, 2021.
According to the needs of the patient's diagnosis and treatment, the long-term prescription is generally within 4 weeks.
In areas with conditions, it can be extended appropriately according to the characteristics of chronic diseases, and the longest is no more than 12 weeks.
According to actual conditions, various regions need to formulate long-term prescription applicable diseases and long-term prescription drugs.
It is worth noting that long-term prescriptions are encouraged by primary medical and health institutions.
When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs, national centralized procurement drugs, and national medical insurance catalog drugs.
After the doctor has issued a long-term prescription, the patient can choose to dispense and take medicine at medical institutions or social retail pharmacies.
The deadline for feedback on the "Draft of Opinions" is May 1, 2021.
Class8 drugs cannot be used for long prescriptions
Long-term prescriptions refer to those prescribed by qualified physicians in accordance with regulations to appropriately increase the amount of prescriptions prescribed by qualified patients with chronic diseases.
It is suitable for patients with chronic diseases with clear clinical diagnosis, stable medication regimen, good compliance, stable disease control, and long-term drug treatment.
Commonly used drugs for the treatment of chronic diseases can be used for long-term prescriptions.
Toxic drugs for medical use, radioactive drugs, precursor drugs, narcotic drugs, psychotropic drugs, biological agents, antibacterial drugs (except drugs for the treatment of chronic bacterial and fungal infectious diseases such as tuberculosis), and drugs with special requirements for storage conditions shall not be used For long-term prescription.
It is suitable for patients with chronic diseases with clear clinical diagnosis, stable medication regimen, good compliance, stable disease control, and long-term drug treatment.
Commonly used drugs for the treatment of chronic diseases can be used for long-term prescriptions.
Toxic drugs for medical use, radioactive drugs, precursor drugs, narcotic drugs, psychotropic drugs, biological agents, antibacterial drugs (except drugs for the treatment of chronic bacterial and fungal infectious diseases such as tuberculosis), and drugs with special requirements for storage conditions shall not be used For long-term prescription.
Regarding the prescribing conditions and which medical institutions can prescribe long-term prescriptions, the "Draft Opinions" clarifies that medical institutions that prescribe long-term prescriptions should be equipped with physicians who have the ability to assess the patient's condition, pharmacists who can review and adjust long-term prescriptions, and corresponding equipment and facilities.
Long-term prescriptions for chronic diseases that are not suitable for primary treatment should be issued by medical institutions above the second level.
If the primary medical and health institution does not have the corresponding conditions, it can be issued under the guidance of the qualified higher-level medical institution in the medical consortium through telemedicine and other routes.
At the same time, grassroots medical and health institutions should strengthen the allocation of drugs in the long-term prescription drug catalog to ensure that patients' long-term medication is accessible and stable.
Long-term prescriptions for chronic diseases that are not suitable for primary treatment should be issued by medical institutions above the second level.
If the primary medical and health institution does not have the corresponding conditions, it can be issued under the guidance of the qualified higher-level medical institution in the medical consortium through telemedicine and other routes.
At the same time, grassroots medical and health institutions should strengthen the allocation of drugs in the long-term prescription drug catalog to ensure that patients' long-term medication is accessible and stable.
In addition, the National Health Commission also puts forward strict requirements on the issuance and termination of long-term prescriptions.
In the diagnosis and treatment activities, doctors can proactively propose long-term prescription recommendations to eligible patients, and explain to patients the precautions for using long-term prescriptions.
Choose whether to use it voluntarily.
For the first long-term prescription, the physician should conduct a comprehensive assessment of the patient’s past history, current medical history, medication regimen, compliance, disease control, etc.
, and only when the current medication regimen is determined to be safe, effective, and stable, can the patient be prescribed Long-term prescription.
In the diagnosis and treatment activities, doctors can proactively propose long-term prescription recommendations to eligible patients, and explain to patients the precautions for using long-term prescriptions.
Choose whether to use it voluntarily.
For the first long-term prescription, the physician should conduct a comprehensive assessment of the patient’s past history, current medical history, medication regimen, compliance, disease control, etc.
, and only when the current medication regimen is determined to be safe, effective, and stable, can the patient be prescribed Long-term prescription.
In principle, the first long-term prescription should be issued by a doctor with an intermediate or higher qualification for a disease-related professional in a medical institution above the second level, or by a doctor with an intermediate or higher qualification for a professional and technical position in a primary medical and health institution.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
After the doctor has issued a long-term prescription, the patient can choose to dispense the medicine at a medical institution or social retail pharmacy.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
After the doctor has issued a long-term prescription, the patient can choose to dispense the medicine at a medical institution or social retail pharmacy.
Regarding the formulation of the long-term prescription drug list that the industry is most concerned about, the National Health Commission has made it clear that the local government should formulate a long-term prescription for diseases and long-term prescription drugs based on actual conditions.
When medical institutions issue long-term prescriptions, priority should be given to national essential drugs, national organizations' centralized procurement and use of drugs, and national medical insurance catalog drugs.
When medical institutions issue long-term prescriptions, priority should be given to national essential drugs, national organizations' centralized procurement and use of drugs, and national medical insurance catalog drugs.
Basic drugs, medical insurance drugs welcome policy dividends
From the perspective of the industry, standardizing long-term prescription management can promote hierarchical diagnosis and treatment and promote rational drug use.
In recent years, many places across the country have successively introduced policies to explore the implementation of long-term prescriptions for chronic diseases.
The sudden outbreak of new crown pneumonia has accelerated the implementation of this policy.
In February last year, the National Medical Insurance Administration issued a notice on optimizing medical security handling services to promote the prevention and control of pneumonia epidemic caused by new coronavirus infection, encouraging support for long-term prescriptions.
For patients with chronic diseases such as hypertension and diabetes, the prescribed medication amount will be relaxed to 3 months.
Subsequently, the State Council’s response to the new crown epidemic joint prevention and control mechanism medical treatment team issued the "Notice on Doing a Good Job in the Management of Current Long-term Drug Prescriptions for Chronic Diseases", encouraging the formulation and improvement of long-term prescription management policies for patients with chronic diseases based on local conditions.
In recent years, many places across the country have successively introduced policies to explore the implementation of long-term prescriptions for chronic diseases.
The sudden outbreak of new crown pneumonia has accelerated the implementation of this policy.
In February last year, the National Medical Insurance Administration issued a notice on optimizing medical security handling services to promote the prevention and control of pneumonia epidemic caused by new coronavirus infection, encouraging support for long-term prescriptions.
For patients with chronic diseases such as hypertension and diabetes, the prescribed medication amount will be relaxed to 3 months.
Subsequently, the State Council’s response to the new crown epidemic joint prevention and control mechanism medical treatment team issued the "Notice on Doing a Good Job in the Management of Current Long-term Drug Prescriptions for Chronic Diseases", encouraging the formulation and improvement of long-term prescription management policies for patients with chronic diseases based on local conditions.
Under the policy of vigorously promoting long-term prescriptions for chronic diseases, various places have successively carried out exploration and pilot projects.
In July 2020, the Hainan Provincial Health Commission issued the "Notice on Printing and Distributing the Long-term Prescription Management Regulations for Medical Institutions in Hainan Province (for Trial Implementation) and the List of Long-term Prescription Drugs in Hainan Province (for Trial Implementation)".
The catalog includes 137 varieties, and is divided into 9 categories of drugs such as hypertension, diabetes, dyslipidemia, chronic obstructive pulmonary disease, and chronic kidney.
In terms of varieties, a number of nationally collected varieties, major clinical varieties and some new drugs have been included.
In accordance with the requirements of the National Health Commission, more provinces and cities will release long-term prescription drug lists in the future.
In July 2020, the Hainan Provincial Health Commission issued the "Notice on Printing and Distributing the Long-term Prescription Management Regulations for Medical Institutions in Hainan Province (for Trial Implementation) and the List of Long-term Prescription Drugs in Hainan Province (for Trial Implementation)".
The catalog includes 137 varieties, and is divided into 9 categories of drugs such as hypertension, diabetes, dyslipidemia, chronic obstructive pulmonary disease, and chronic kidney.
In terms of varieties, a number of nationally collected varieties, major clinical varieties and some new drugs have been included.
In accordance with the requirements of the National Health Commission, more provinces and cities will release long-term prescription drug lists in the future.
As the long-term prescription policy is rolled out, it will be complemented by graded diagnosis and treatment, and prescription sinking will accelerate.
At the same time, in accordance with the long-term prescription policy, patients can choose to dispense medicines in medical institutions or social retail pharmacies, and the outflow of prescriptions will send a positive signal.
From the perspective of the industry, the long-term prescription policy is conducive to increasing compliance with the use of drugs.
The drugs included in the long-term prescription list will usher in an increase in expectations, and the basic drug list, the medical insurance list of drugs, and the nationally collected products will give priority to this wave of market dividends.
.
At the same time, in accordance with the long-term prescription policy, patients can choose to dispense medicines in medical institutions or social retail pharmacies, and the outflow of prescriptions will send a positive signal.
From the perspective of the industry, the long-term prescription policy is conducive to increasing compliance with the use of drugs.
The drugs included in the long-term prescription list will usher in an increase in expectations, and the basic drug list, the medical insurance list of drugs, and the nationally collected products will give priority to this wave of market dividends.
.
Long-term prescription management practices
(Trial draft for soliciting comments)
Chapter I General Provisions
Article 1 Standardize long-term prescription management, promote hierarchical diagnosis and treatment, promote rational use of drugs, and ensure medical quality and safety.
According to the "Practicing Physician Law", "Drug Administration Law", "Medical Institution Management Regulations", "Narcotic Drugs and Psychotropic Drugs Management Regulations", The Regulations on Prescription Management, "Regulations on the Administration of Pharmaceutical Affairs in Medical Institutions," and other relevant regulations have formulated this specification.
According to the "Practicing Physician Law", "Drug Administration Law", "Medical Institution Management Regulations", "Narcotic Drugs and Psychotropic Drugs Management Regulations", The Regulations on Prescription Management, "Regulations on the Administration of Pharmaceutical Affairs in Medical Institutions," and other relevant regulations have formulated this specification.
Article 2 The term “long-term prescriptions” as used in this specification refers to the prescriptions prescribed by qualified physicians in accordance with regulations to appropriately increase the amount of prescriptions prescribed by qualified patients with chronic diseases.
Article 3 Long-term prescriptions are suitable for patients with chronic diseases with clear clinical diagnosis, stable medication regimen, good compliance, stable disease control, and long-term drug treatment.
Article 4 Commonly used drugs for the treatment of chronic diseases can be used for long-term prescriptions.
Toxic drugs for medical use, radioactive drugs, precursor drugs, narcotic drugs, psychotropic drugs, biological agents, antibacterial drugs (except drugs for the treatment of chronic bacterial and fungal infectious diseases such as tuberculosis), and drugs with special requirements for storage conditions shall not be used For long-term prescription.
Toxic drugs for medical use, radioactive drugs, precursor drugs, narcotic drugs, psychotropic drugs, biological agents, antibacterial drugs (except drugs for the treatment of chronic bacterial and fungal infectious diseases such as tuberculosis), and drugs with special requirements for storage conditions shall not be used For long-term prescription.
Article 5 The local administrative department of health and health shall, based on actual conditions, formulate a list of diseases and diseases applicable to long-term prescriptions and drugs for long-term prescriptions.
Article 6 This specification applies to the long-term prescription management work of various medical institutions at all levels and types across the country.
Long-term prescriptions for chronic diseases that are not suitable for primary treatment should be issued by medical institutions above the second level.
Article 7 The National Health Commission is responsible for the supervision and management of long-term prescriptions nationwide.
Local health administrative departments at or above the county level are responsible for the supervision and management of long-term prescriptions within their administrative areas.
Chapter II Organization Management
Article 8 A medical institution shall perform its main responsibility for long-term prescription management, establish and improve its long-term prescription management work system, ensure medical quality and medical safety, and meet the needs of patients for medication.
Article 9 Medical institutions that issue long-term prescriptions should be equipped with physicians who have the ability to assess patients' conditions, pharmacists who can review and adjust long-term prescriptions, and corresponding equipment and facilities.
If the primary medical and health institution does not have the corresponding conditions, it can be issued under the guidance of the qualified superior medical institution in the medical consortium through telemedicine and other routes.
Article 10 According to the needs of patients for diagnosis and treatment, the amount of long-term prescriptions is generally within 4 weeks, and in areas where conditions permit, it can be extended appropriately according to the characteristics of chronic diseases, and the longest will not exceed 12 weeks.
For long-term prescriptions exceeding 4 weeks, physicians should strictly evaluate, strengthen patient education, and record in the medical record, and the patient should sign for confirmation.
，。
，，。
，、。
，。
，。
，；，。
，、、、、，、、，。，。
，，。，，。。
，。
，。，；，。，。
，，：
(1) The patient's long-term medication management fails to reach the expected goal;
(2) Suffering from other diseases requires other medication;
(3) The patient is hospitalized for any reason;
(4) Other circumstances requiring termination of long-term prescriptions.
Article 20 The primary medical and health institutions that issue long-term prescriptions and the higher-level hospitals must do a good job of linking up, and establish a patient prescription information sharing and circulation mechanism through informatization methods.
Article 21 The form and content of long-term prescriptions shall comply with the requirements of ordinary prescription management in the "Prescription Management Measures".
Chapter IV long-term prescription swap
Article 22 After a doctor has issued a long-term prescription, the patient may choose to dispense and take medicine at a medical institution or social retail pharmacy .
Article 23 Pharmacists review long-term prescriptions, provide medication guidance and medication education to patients, and distribute medication education materials.
If the primary medical and health institutions do not have the conditions, the pharmacists of the higher-level hospitals in the medical association shall remotely conduct prescription review or provide medication guidance services through the Internet.
If the primary medical and health institutions do not have the conditions, the pharmacists of the higher-level hospitals in the medical association shall remotely conduct prescription review or provide medication guidance services through the Internet.
Article 24 When pharmacists review long-term prescriptions, provide consulting services, or dispense drugs, if they discover drug treatment-related problems or patients have potential drug safety risks, and need to carry out long-term prescription adjustments, drug reorganizations and other interventions, they should immediately contact the physician Communicate for processing.
Article 25 In principle, long-term prescription drugs shall be collected by the patient himself.
Under special circumstances, due to inconvenience and other reasons, personnel who are familiar with the basic situation of the patient can pick up the card on behalf of the person and the patient with a valid ID card.
Under special circumstances, due to inconvenience and other reasons, personnel who are familiar with the basic situation of the patient can pick up the card on behalf of the person and the patient with a valid ID card.
Chapter V long-term prescription medication management
Article 26 Primary medical and health institutions shall include the long-term prescription information issued by the institution in the patient's health file, and record the patient's diagnosis and treatment and medication records in detail.
The family doctor team should conduct regular follow-up management of patients, evaluate changes in the patient's condition, medication compliance, and adverse drug reactions, and adjust or terminate long-term prescriptions if necessary.
The family doctor team should conduct regular follow-up management of patients, evaluate changes in the patient's condition, medication compliance, and adverse drug reactions, and adjust or terminate long-term prescriptions if necessary.
Article 27 Medical institutions shall establish safe medication monitoring and reporting systems.
After a serious adverse drug event occurs, the patient should be actively treated, immediately reported to the medical and pharmaceutical departments, and observed and recorded.
Report adverse drug reactions and other information to relevant departments in accordance with relevant regulations.
After a serious adverse drug event occurs, the patient should be actively treated, immediately reported to the medical and pharmaceutical departments, and observed and recorded.
Report adverse drug reactions and other information to relevant departments in accordance with relevant regulations.
Article 28 Medical institutions shall strengthen medication education for patients who use long-term prescriptions, increase their knowledge of rational medication, improve self-administration of medication and medication compliance, and inform patients that they should see a doctor promptly if they experience any discomfort during medication.
Article 29 Medical institutions shall instruct patients who use long-term prescriptions to self-monitor and keep records of drug treatment effect indicators.
Encourage the use of wearable devices to improve the informatization level of drug treatment effect indicator monitoring.
On the premise of ensuring the safety of data and privacy, it is possible to explore the use of remote monitoring equipment connected to the Internet to carry out monitoring.
Encourage the use of wearable devices to improve the informatization level of drug treatment effect indicator monitoring.
On the premise of ensuring the safety of data and privacy, it is possible to explore the use of remote monitoring equipment connected to the Internet to carry out monitoring.
Article 30 Medical institutions shall instruct patients who use long-term prescriptions, preserve medicines as required, and ensure the quality of medicines.
Article 31 Medical institutions shall incorporate the diagnosis and treatment of patients with long-term prescriptions into the overall arrangements for medical management, strictly implement the requirements for the diagnosis and treatment of relevant diseases, strengthen quality control and management, and ensure medical quality and medical safety.
Article 32: Encourage regions with conditions to open WeChat official accounts, patient clients, etc.
, to facilitate patients' inquiries about long-term prescription information, drug usage and dosage, precautions, etc.
Explore the development of medication reminder, follow-up, medication consultation and other services for patients with long-term prescriptions.
, to facilitate patients' inquiries about long-term prescription information, drug usage and dosage, precautions, etc.
Explore the development of medication reminder, follow-up, medication consultation and other services for patients with long-term prescriptions.
Chapter VI Supplementary Provisions
Article 33 The local administrative department of health and health shall formulate and implement detailed rules for the management of long-term prescriptions within its jurisdiction.
Article 34: Primary medical and health institutions refer to township health centers, community health service centers (stations), village clinics, infirmaries, outpatient departments and clinics, etc.
Article 35 This specification shall come into force on the date of issuance.
Medical Network, April 2 News On April 1, the Medical Administration and Hospital Administration of the National Health Commission issued the "Management Standards for Long-term Prescriptions (Trial Draft for Solicitation of Comments)" (hereinafter referred to as the "Draft for Comments").
According to the needs of the patient's diagnosis and treatment, the long-term prescription is generally within 4 weeks.
In areas with conditions, it can be extended appropriately according to the characteristics of chronic diseases, and the longest is no more than 12 weeks.
According to actual conditions, various regions need to formulate long-term prescription applicable diseases and long-term prescription drugs.
It is worth noting that long-term prescriptions are encouraged by primary medical and health institutions.
When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs, national centralized procurement drugs, and national medical insurance catalog drugs.
After the doctor has issued a long-term prescription, the patient can choose to dispense and take medicine at medical institutions or social retail pharmacies.
The deadline for feedback on the "Draft of Opinions" is May 1, 2021.
According to the needs of the patient's diagnosis and treatment, the long-term prescription is generally within 4 weeks.
In areas with conditions, it can be extended appropriately according to the characteristics of chronic diseases, and the longest is no more than 12 weeks.
According to actual conditions, various regions need to formulate long-term prescription applicable diseases and long-term prescription drugs.
It is worth noting that long-term prescriptions are encouraged by primary medical and health institutions.
When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs, national centralized procurement drugs, and national medical insurance catalog drugs.
After the doctor has issued a long-term prescription, the patient can choose to dispense and take medicine at medical institutions or social retail pharmacies.
The deadline for feedback on the "Draft of Opinions" is May 1, 2021.
Class 8 drugs cannot be used for long prescriptions
Long-term prescriptions refer to those prescribed by qualified physicians in accordance with regulations to appropriately increase the amount of prescriptions prescribed by qualified patients with chronic diseases.
It is suitable for patients with chronic diseases with clear clinical diagnosis, stable medication regimen, good compliance, stable disease control, and long-term drug treatment.
Commonly used drugs for the treatment of chronic diseases can be used for long-term prescriptions.
Toxic drugs for medical use, radioactive drugs, precursor drugs, narcotic drugs, psychotropic drugs, biological agents, antibacterial drugs (except drugs for the treatment of chronic bacterial and fungal infectious diseases such as tuberculosis), and drugs with special requirements for storage conditions shall not be used For long-term prescription.
It is suitable for patients with chronic diseases with clear clinical diagnosis, stable medication regimen, good compliance, stable disease control, and long-term drug treatment.
Commonly used drugs for the treatment of chronic diseases can be used for long-term prescriptions.
Toxic drugs for medical use, radioactive drugs, precursor drugs, narcotic drugs, psychotropic drugs, biological agents, antibacterial drugs (except drugs for the treatment of chronic bacterial and fungal infectious diseases such as tuberculosis), and drugs with special requirements for storage conditions shall not be used For long-term prescription.
Regarding the prescribing conditions and which medical institutions can prescribe long-term prescriptions, the "Draft Opinions" clarifies that medical institutions that prescribe long-term prescriptions should be equipped with physicians who have the ability to assess the patient's condition, pharmacists who can review and adjust long-term prescriptions, and corresponding equipment and facilities.
Long-term prescriptions for chronic diseases that are not suitable for primary treatment should be issued by medical institutions above the second level.
If the primary medical and health institution does not have the corresponding conditions, it can be issued under the guidance of the qualified higher-level medical institution in the medical consortium through telemedicine and other routes.
At the same time, grassroots medical and health institutions should strengthen the allocation of drugs in the long-term prescription drug catalog to ensure that patients' long-term medication is accessible and stable.
Long-term prescriptions for chronic diseases that are not suitable for primary treatment should be issued by medical institutions above the second level.
If the primary medical and health institution does not have the corresponding conditions, it can be issued under the guidance of the qualified higher-level medical institution in the medical consortium through telemedicine and other routes.
At the same time, grassroots medical and health institutions should strengthen the allocation of drugs in the long-term prescription drug catalog to ensure that patients' long-term medication is accessible and stable.
In addition, the National Health Commission also puts forward strict requirements on the issuance and termination of long-term prescriptions.
In the diagnosis and treatment activities, doctors can proactively propose long-term prescription recommendations to eligible patients, and explain to patients the precautions for using long-term prescriptions.
Choose whether to use it voluntarily.
For the first long-term prescription, the physician should conduct a comprehensive assessment of the patient’s past history, current medical history, medication regimen, compliance, disease control, etc.
, and only when the current medication regimen is determined to be safe, effective, and stable, can the patient be prescribed Long-term prescription.
In the diagnosis and treatment activities, doctors can proactively propose long-term prescription recommendations to eligible patients, and explain to patients the precautions for using long-term prescriptions.
Choose whether to use it voluntarily.
For the first long-term prescription, the physician should conduct a comprehensive assessment of the patient’s past history, current medical history, medication regimen, compliance, disease control, etc.
, and only when the current medication regimen is determined to be safe, effective, and stable, can the patient be prescribed Long-term prescription.
In principle, the first long-term prescription should be issued by a doctor with an intermediate or higher qualification for a disease-related professional in a medical institution above the second level, or by a doctor with an intermediate or higher qualification for a professional and technical position in a primary medical and health institution.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
After the doctor has issued a long-term prescription, the patient can choose to dispense the medicine at a medical institution or social retail pharmacy.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
After the doctor has issued a long-term prescription, the patient can choose to dispense the medicine at a medical institution or social retail pharmacy.
Regarding the formulation of the long-term prescription drug list that the industry is most concerned about, the National Health Commission has made it clear that the local government should formulate a long-term prescription for diseases and long-term prescription drugs based on actual conditions.
When medical institutions issue long-term prescriptions, priority should be given to national essential drugs, national organizations' centralized procurement and use of drugs, and national medical insurance catalog drugs.
When medical institutions issue long-term prescriptions, priority should be given to national essential drugs, national organizations' centralized procurement and use of drugs, and national medical insurance catalog drugs.
Basic drugs, medical insurance drugs welcome policy dividends
From the perspective of the industry, standardizing long-term prescription management can promote hierarchical diagnosis and treatment and promote rational drug use.
In recent years, many places across the country have successively introduced policies to explore the implementation of long-term prescriptions for chronic diseases.
The sudden outbreak of new crown pneumonia has accelerated the implementation of this policy.
In February last year, the National Medical Insurance Administration issued a notice on optimizing medical security handling services to promote the prevention and control of pneumonia epidemic caused by new coronavirus infection, encouraging support for long-term prescriptions.
For patients with chronic diseases such as hypertension and diabetes, the prescribed medication amount will be relaxed to 3 months.
Subsequently, the State Council’s response to the new crown epidemic joint prevention and control mechanism medical treatment team issued the "Notice on Doing a Good Job in the Management of Current Long-term Drug Prescriptions for Chronic Diseases", encouraging the formulation and improvement of long-term prescription management policies for patients with chronic diseases based on local conditions.
In recent years, many places across the country have successively introduced policies to explore the implementation of long-term prescriptions for chronic diseases.
The sudden outbreak of new crown pneumonia has accelerated the implementation of this policy.
In February last year, the National Medical Insurance Administration issued a notice on optimizing medical security handling services to promote the prevention and control of pneumonia epidemic caused by new coronavirus infection, encouraging support for long-term prescriptions.
For patients with chronic diseases such as hypertension and diabetes, the prescribed medication amount will be relaxed to 3 months.
Subsequently, the State Council’s response to the new crown epidemic joint prevention and control mechanism medical treatment team issued the "Notice on Doing a Good Job in the Management of Current Long-term Drug Prescriptions for Chronic Diseases", encouraging the formulation and improvement of long-term prescription management policies for patients with chronic diseases based on local conditions.
Under the policy of vigorously promoting long-term prescriptions for chronic diseases, various places have successively carried out exploration and pilot projects.
In July 2020, the Hainan Provincial Health Commission issued the "Notice on Printing and Distributing the Long-term Prescription Management Regulations for Medical Institutions in Hainan Province (for Trial Implementation) and the List of Long-term Prescription Drugs in Hainan Province (for Trial Implementation)".
The catalog includes 137 varieties, and is divided into 9 categories of drugs such as hypertension, diabetes, dyslipidemia, chronic obstructive pulmonary disease, and chronic kidney.
In terms of varieties, a number of nationally collected varieties, major clinical varieties and some new drugs have been included.
In accordance with the requirements of the National Health Commission, more provinces and cities will release long-term prescription drug lists in the future.
In July 2020, the Hainan Provincial Health Commission issued the "Notice on Printing and Distributing the Long-term Prescription Management Regulations for Medical Institutions in Hainan Province (for Trial Implementation) and the List of Long-term Prescription Drugs in Hainan Province (for Trial Implementation)".
The catalog includes 137 varieties, and is divided into 9 categories of drugs such as hypertension, diabetes, dyslipidemia, chronic obstructive pulmonary disease, and chronic kidney.
In terms of varieties, a number of nationally collected varieties, major clinical varieties and some new drugs have been included.
In accordance with the requirements of the National Health Commission, more provinces and cities will release long-term prescription drug lists in the future.
As the long-term prescription policy is rolled out, it will be complemented by graded diagnosis and treatment, and prescription sinking will accelerate.
At the same time, in accordance with the long-term prescription policy, patients can choose to dispense medicines in medical institutions or social retail pharmacies, and the outflow of prescriptions will send a positive signal.
From the perspective of the industry, the long-term prescription policy is conducive to increasing compliance with the use of drugs.
The drugs included in the long-term prescription list will usher in an increase in expectations, and the basic drug list, the medical insurance list of drugs, and the nationally collected products will give priority to this wave of market dividends.
.
At the same time, in accordance with the long-term prescription policy, patients can choose to dispense medicines in medical institutions or social retail pharmacies, and the outflow of prescriptions will send a positive signal.
From the perspective of the industry, the long-term prescription policy is conducive to increasing compliance with the use of drugs.
The drugs included in the long-term prescription list will usher in an increase in expectations, and the basic drug list, the medical insurance list of drugs, and the nationally collected products will give priority to this wave of market dividends.
.
Long-term prescription management practices
(Trial draft for soliciting comments)
Chapter I General Provisions
，，，，《》《》《》《》《》《》，。
，。
、、、、。
。、、、、、、（），。
，。
。
，。
。
。
，，，。
，、。
，。
，4，，12。
4，，，，。
Article 11 Medical institutions shall provide long-term prescription services to eligible patients in accordance with the long-term prescription applicable disease types and the long-term prescription drug list formulated by the health administrative department.
Article 12 When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs.
The state organizes centralized procurement and use of drugs and drugs in the national medical insurance catalogue.
The state organizes centralized procurement and use of drugs and drugs in the national medical insurance catalogue.
Article 13 Primary medical and health institutions shall strengthen the provision of drugs in the long-term prescription drug catalog to ensure that patients' long-term medication is accessible and stable.
Chapter III long-term prescriptions issued and Termination
Article 14 For patients who apply for long-term prescriptions, doctors must conduct medical examinations in person and make judgments on whether they meet the conditions for long-term prescriptions.
During the diagnosis and treatment activities, doctors can proactively propose long-term prescription recommendations to eligible patients.
Article 15 Physicians should explain to patients the precautions for using long-term prescriptions, and they should voluntarily choose whether to use them; for patients who do not meet the conditions, they should explain the reasons to the patients.
Article 16 Before issuing a long-term prescription for the first time, the physician shall conduct a comprehensive assessment of the patient’s past history, current medical history, medication regimen, compliance, disease control, etc.
, and formulate a prescription when the current medication regimen is determined to be safe, effective, and stable.
Long-term prescriptions can be prescribed for patients.
When a long-term prescription is issued for the first time, relevant information should be recorded in detail in the patient's medical record.
, and formulate a prescription when the current medication regimen is determined to be safe, effective, and stable.
Long-term prescriptions can be prescribed for patients.
When a long-term prescription is issued for the first time, relevant information should be recorded in detail in the patient's medical record.
Article 17: In principle, the first long-term prescription should be issued by a doctor with a qualification for an intermediate or above professional and technical position in a disease-related medical institution at a secondary level or above, or by a doctor with an intermediate or above professional and technical qualification for a primary medical and health institution.
Issued.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
Issued.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
For remote areas or areas where conditions are not available, the requirements may be appropriately relaxed, and the specific requirements shall be separately formulated by the provincial health administrative department based on the actual situation.
Article 18 Physicians should evaluate patients based on the long-term prescription information and health files issued for the first time in the patient's medical record information.
After evaluation, if the patient's condition is stable and the long-term medication management goal is reached, the long-term prescription can be issued again; if the condition is not met, the long-term prescription shall be terminated.
If the long-term prescription is used again after stopping, it shall be managed according to the long-term prescription issued for the first time.
After evaluation, if the patient's condition is stable and the long-term medication management goal is reached, the long-term prescription can be issued again; if the condition is not met, the long-term prescription shall be terminated.
If the long-term prescription is used again after stopping, it shall be managed according to the long-term prescription issued for the first time.
Article 19 In the following situations, it is necessary to reassess the patient's condition and determine whether to terminate the long-term prescription:
(1) The patient's long-term medication management fails to reach the expected goal;
(2) Suffering from other diseases requires other medication;
(3) The patient is hospitalized for any reason;
(4) Other circumstances requiring termination of long-term prescriptions.
Article 20 The primary medical and health institutions that issue long-term prescriptions and the higher-level hospitals must do a good job of linking up, and establish a patient prescription information sharing and circulation mechanism through informatization methods.
Article 21 The form and content of long-term prescriptions shall comply with the requirements of ordinary prescription management in the "Prescription Management Measures".
Chapter IV long-term prescription swap
Article 22 After a doctor has issued a long-term prescription, the patient may choose to dispense and take medicine at a medical institution or social retail pharmacy .
Article 23 Pharmacists review long-term prescriptions, provide medication guidance and medication education to patients, and distribute medication education materials.
If the primary medical and health institutions do not have the conditions, the pharmacists of the higher-level hospitals in the medical association shall remotely conduct prescription review or provide medication guidance services through the Internet.
If the primary medical and health institutions do not have the conditions, the pharmacists of the higher-level hospitals in the medical association shall remotely conduct prescription review or provide medication guidance services through the Internet.
Article 24 When pharmacists review long-term prescriptions, provide consulting services, or dispense drugs, if they discover drug treatment-related problems or patients have potential drug safety risks, and need to carry out long-term prescription adjustments, drug reorganizations and other interventions, they should immediately contact the physician Communicate for processing.
Article 25 In principle, long-term prescription drugs shall be collected by the patient himself.
Under special circumstances, due to inconvenience and other reasons, personnel who are familiar with the basic situation of the patient can pick up the card on behalf of the person and the patient with a valid ID card.
Under special circumstances, due to inconvenience and other reasons, personnel who are familiar with the basic situation of the patient can pick up the card on behalf of the person and the patient with a valid ID card.
Chapter V long-term prescription medication management
Article 26 Primary medical and health institutions shall include the long-term prescription information issued by the institution in the patient's health file, and record the patient's diagnosis and treatment and medication records in detail.
The family doctor team should conduct regular follow-up management of patients, evaluate changes in the patient's condition, medication compliance, and adverse drug reactions, and adjust or terminate long-term prescriptions if necessary.
The family doctor team should conduct regular follow-up management of patients, evaluate changes in the patient's condition, medication compliance, and adverse drug reactions, and adjust or terminate long-term prescriptions if necessary.
Article 27 Medical institutions shall establish safe medication monitoring and reporting systems.
After a serious adverse drug event occurs, the patient should be actively treated, immediately reported to the medical and pharmaceutical departments, and observed and recorded.
Report adverse drug reactions and other information to relevant departments in accordance with relevant regulations.
After a serious adverse drug event occurs, the patient should be actively treated, immediately reported to the medical and pharmaceutical departments, and observed and recorded.
Report adverse drug reactions and other information to relevant departments in accordance with relevant regulations.
Article 28 Medical institutions shall strengthen medication education for patients who use long-term prescriptions, increase their knowledge of rational medication, improve self-administration of medication and medication compliance, and inform patients that they should see a doctor promptly if they experience any discomfort during medication.
Article 29 Medical institutions shall instruct patients who use long-term prescriptions to self-monitor and keep records of drug treatment effect indicators.
Encourage the use of wearable devices to improve the informatization level of drug treatment effect indicator monitoring.
On the premise of ensuring the safety of data and privacy, it is possible to explore the use of remote monitoring equipment connected to the Internet to carry out monitoring.
Encourage the use of wearable devices to improve the informatization level of drug treatment effect indicator monitoring.
On the premise of ensuring the safety of data and privacy, it is possible to explore the use of remote monitoring equipment connected to the Internet to carry out monitoring.
Article 30 Medical institutions shall instruct patients who use long-term prescriptions, preserve medicines as required, and ensure the quality of medicines.
Article 31 Medical institutions shall incorporate the diagnosis and treatment of patients with long-term prescriptions into the overall arrangements for medical management, strictly implement the requirements for the diagnosis and treatment of relevant diseases, strengthen quality control and management, and ensure medical quality and medical safety.
Article 32: Encourage regions with conditions to open WeChat official accounts, patient clients, etc.
, to facilitate patients' inquiries about long-term prescription information, drug usage and dosage, precautions, etc.
Explore the development of medication reminder, follow-up, medication consultation and other services for patients with long-term prescriptions.
, to facilitate patients' inquiries about long-term prescription information, drug usage and dosage, precautions, etc.
Explore the development of medication reminder, follow-up, medication consultation and other services for patients with long-term prescriptions.
Chapter VI Supplementary Provisions
Article 33 The local administrative department of health and health shall formulate and implement detailed rules for the management of long-term prescriptions within its jurisdiction.
Article 34: Primary medical and health institutions refer to township health centers, community health service centers (stations), village clinics, infirmaries, outpatient departments and clinics, etc.
Article 35 This specification shall come into force on the date of issuance.
Medical Network, April 2 News On April 1, the Medical Administration and Hospital Administration of the National Health Commission issued the "Management Standards for Long-term Prescriptions (Trial Draft for Solicitation of Comments)" (hereinafter referred to as the "Draft for Comments").
According to the needs of the patient's diagnosis and treatment, the long-term prescription is generally within 4 weeks.
In areas with conditions, it can be extended appropriately according to the characteristics of chronic diseases, and the longest is no more than 12 weeks.
According to actual conditions, various regions need to formulate long-term prescription applicable diseases and long-term prescription drugs.
It is worth noting that long-term prescriptions are encouraged by primary medical and health institutions.
When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs, national centralized procurement drugs, and national medical insurance catalog drugs.
After the doctor has issued a long-term prescription, the patient can choose to dispense and take medicine at medical institutions or social retail pharmacies.
The deadline for feedback on the "Draft of Opinions" is May 1, 2021.
According to the needs of the patient's diagnosis and treatment, the long-term prescription is generally within 4 weeks.
In areas with conditions, it can be extended appropriately according to the characteristics of chronic diseases, and the longest is no more than 12 weeks.
According to actual conditions, various regions need to formulate long-term prescription applicable diseases and long-term prescription drugs.
It is worth noting that long-term prescriptions are encouraged by primary medical and health institutions.
When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs, national centralized procurement drugs, and national medical insurance catalog drugs.
After the doctor has issued a long-term prescription, the patient can choose to dispense and take medicine at medical institutions or social retail pharmacies.
The deadline for feedback on the "Draft of Opinions" is May 1, 2021.
8
8 ，。、、、、。。、、、、、、（），。
、，《》，，、。，。，。，，、。
，，，，，。，、、、、，、、，。
，，。，，。。，。
，：，。，、。
、
、 ，，，。，。。2，《》，。、，3。，《》，，。
，。20207，《（）（）》。137，、、、、9。，、。，。
，，。，，，。，，，、，。
（ ）
（ ） ，，，，《》《》《》《》《》《》，。
，。
、、、、。
。、、、、、、（），。
，。
。
，。
。
。
Article 8 A medical institution shall perform its main responsibility for long-term prescription management, establish and improve its long-term prescription management work system, ensure medical quality and medical safety, and meet the needs of patients for medication.
Article 9 Medical institutions that issue long-term prescriptions should be equipped with physicians who have the ability to assess patients' conditions, pharmacists who can review and adjust long-term prescriptions, and corresponding equipment and facilities.
If the primary medical and health institution does not have the corresponding conditions, it can be issued under the guidance of the qualified superior medical institution in the medical consortium through telemedicine and other routes.
Article 10 According to the needs of patients for diagnosis and treatment, the amount of long-term prescriptions is generally within 4 weeks, and in areas where conditions permit, it can be extended appropriately according to the characteristics of chronic diseases, and the longest will not exceed 12 weeks.
For long-term prescriptions exceeding 4 weeks, physicians should strictly evaluate, strengthen patient education, and record in the medical record, and the patient should sign for confirmation.
Article 11 Medical institutions shall provide long-term prescription services to eligible patients in accordance with the long-term prescription applicable disease types and the long-term prescription drug list formulated by the health administrative department.
Article 12 When issuing long-term prescriptions, medical institutions shall give priority to the selection of national essential drugs.
The state organizes centralized procurement and use of drugs and drugs in the national medical insurance catalogue.
The state organizes centralized procurement and use of drugs and drugs in the national medical insurance catalogue.
Article 13 Primary medical and health institutions shall strengthen the provision of drugs in the long-term prescription drug catalog to ensure that patients' long-term medication is accessible and stable.
Chapter III long-term prescriptions issued and Termination
Chapter III long-term prescriptions issued and Termination Article 14 For patients who apply for long-term prescriptions, doctors must conduct medical examinations in person and make judgments on whether they meet the conditions for long-term prescriptions.
During the diagnosis and treatment activities, doctors can proactively propose long-term prescription recommendations to eligible patients.
Article 15 Physicians should explain to patients the precautions for using long-term prescriptions, and they should voluntarily choose whether to use them; for patients who do not meet the conditions, they should explain the reasons to the patients.
Article 16 Before issuing a long-term prescription for the first time, the physician shall conduct a comprehensive assessment of the patient’s past history, current medical history, medication regimen, compliance, disease control, etc.
, and formulate a prescription when the current medication regimen is determined to be safe, effective, and stable.
Long-term prescriptions can be prescribed for patients.
When a long-term prescription is issued for the first time, relevant information should be recorded in detail in the patient's medical record.
, and formulate a prescription when the current medication regimen is determined to be safe, effective, and stable.
Long-term prescriptions can be prescribed for patients.
When a long-term prescription is issued for the first time, relevant information should be recorded in detail in the patient's medical record.
Article 17: In principle, the first long-term prescription should be issued by a doctor with a qualification for an intermediate or above professional and technical position in a disease-related medical institution at a secondary level or above, or by a doctor with an intermediate or above professional and technical qualification for a primary medical and health institution.
Issued.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
Issued.
When a long-term prescription is issued again, it should be issued by a doctor from a disease-related professional in a medical institution above the second level, or a doctor from a primary medical and health institution.
Encourage patients to sign long-term prescriptions with family doctors through primary medical and health institutions.
For remote areas or areas where conditions are not available, the requirements may be appropriately relaxed, and the specific requirements shall be separately formulated by the provincial health administrative department based on the actual situation.
Article 18 Physicians should evaluate patients based on the long-term prescription information and health files issued for the first time in the patient's medical record information.
After evaluation, if the patient's condition is stable and the long-term medication management goal is reached, the long-term prescription can be issued again; if the condition is not met, the long-term prescription shall be terminated.
If the long-term prescription is used again after stopping, it shall be managed according to the long-term prescription issued for the first time.
After evaluation, if the patient's condition is stable and the long-term medication management goal is reached, the long-term prescription can be issued again; if the condition is not met, the long-term prescription shall be terminated.
If the long-term prescription is used again after stopping, it shall be managed according to the long-term prescription issued for the first time.
Article 19 In the following situations, it is necessary to reassess the patient's condition and determine whether to terminate the long-term prescription:
(1) The patient's long-term medication management fails to reach the expected goal;
(2) Suffering from other diseases requires other medication;
(3) The patient is hospitalized for any reason;
(4) Other circumstances requiring termination of long-term prescriptions.
Article 20 The primary medical and health institutions that issue long-term prescriptions and the higher-level hospitals must do a good job of linking up, and establish a patient prescription information sharing and circulation mechanism through informatization methods.
Hospital hospital hospital Article 21 The form and content of long-term prescriptions shall comply with the requirements of ordinary prescription management in the "Prescription Management Measures".
Chapter IV long-term prescription swap
Chapter IV long-term prescription swap Article 22 After a doctor has issued a long-term prescription, the patient may choose to dispense and take medicine at a medical institution or social retail pharmacy .
Pharmacy pharmacy pharmacy Article 23 Pharmacists review long-term prescriptions, provide medication guidance and medication education to patients, and distribute medication education materials.
If the primary medical and health institutions do not have the conditions, the pharmacists of the higher-level hospitals in the medical association shall remotely conduct prescription review or provide medication guidance services through the Internet.
If the primary medical and health institutions do not have the conditions, the pharmacists of the higher-level hospitals in the medical association shall remotely conduct prescription review or provide medication guidance services through the Internet.
Article 24 When pharmacists review long-term prescriptions, provide consulting services, or dispense drugs, if they discover drug treatment-related problems or patients have potential drug safety risks, and need to carry out long-term prescription adjustments, drug reorganizations and other interventions, they should immediately contact the physician Communicate for processing.
Article 25 In principle, long-term prescription drugs shall be collected by the patient himself.
Under special circumstances, due to inconvenience and other reasons, personnel who are familiar with the basic situation of the patient can pick up the card on behalf of the person and the patient with a valid ID card.
Under special circumstances, due to inconvenience and other reasons, personnel who are familiar with the basic situation of the patient can pick up the card on behalf of the person and the patient with a valid ID card.
Chapter V long-term prescription medication management
Chapter V long-term prescription medication management Article 26 Primary medical and health institutions shall include the long-term prescription information issued by the institution in the patient's health file, and record the patient's diagnosis and treatment and medication records in detail.
The family doctor team should conduct regular follow-up management of patients, evaluate changes in the patient's condition, medication compliance, and adverse drug reactions, and adjust or terminate long-term prescriptions if necessary.
Adverse reactions adverse reactions adverse reactionsThe family doctor team should conduct regular follow-up management of patients, evaluate changes in the patient's condition, medication compliance, and adverse drug reactions, and adjust or terminate long-term prescriptions if necessary.
Article 27 Medical institutions shall establish safe medication monitoring and reporting systems.
After a serious adverse drug event occurs, the patient should be actively treated, immediately reported to the medical and pharmaceutical departments, and observed and recorded.
Report adverse drug reactions and other information to relevant departments in accordance with relevant regulations.
After a serious adverse drug event occurs, the patient should be actively treated, immediately reported to the medical and pharmaceutical departments, and observed and recorded.
Report adverse drug reactions and other information to relevant departments in accordance with relevant regulations.
Article 28 Medical institutions shall strengthen medication education for patients who use long-term prescriptions, increase their knowledge of rational medication, improve self-administration of medication and medication compliance, and inform patients that they should see a doctor promptly if they experience any discomfort during medication.
Article 29 Medical institutions shall instruct patients who use long-term prescriptions to self-monitor and keep records of drug treatment effect indicators.
Encourage the use of wearable devices to improve the informatization level of drug treatment effect indicator monitoring.
On the premise of ensuring the safety of data and privacy, it is possible to explore the use of remote monitoring equipment connected to the Internet to carry out monitoring.
Encourage the use of wearable devices to improve the informatization level of drug treatment effect indicator monitoring.
On the premise of ensuring the safety of data and privacy, it is possible to explore the use of remote monitoring equipment connected to the Internet to carry out monitoring.
Article 30 Medical institutions shall instruct patients who use long-term prescriptions, preserve medicines as required, and ensure the quality of medicines.
，，，，。
、，、、。、、。
。
，、（）、、、。
。
